Biomea Fusion, Inc. (BMEA) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Biomea Fusion reported revenue of $0. Net income was -$61.8M, or -$1.18 per diluted share. Operating activities generated -$70.4M of cash, leaving -$70.7M of free cash flow. At fiscal year end, Biomea Fusion held $58.6M in total assets against $29.0M in total liabilities, including $55.8M of cash and equivalents.
Open the full interactive Biomea Fusion financials → Quarterly statements, key ratios, valuation history and price charts.
Biomea Fusion Key Stats
| Share Price | $1.26 |
|---|---|
| Market Cap | $91.2M |
| 52-Week Range | $0.96 – $2.21 |
| Shares Outstanding | 72.4 million (basic, 2026 Q2) |
Biomea Fusion Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$41.7M | -$83.6M | -$126.1M | -$144.1M | -$83.5M |
| Pre-Tax Income | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M |
| Income Tax | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M |
| Diluted EPS | -$1.74 | -$2.80 | -$3.44 | -$3.83 | -$1.18 |
Biomea Fusion Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$16.4M | $4.6M | -$12.4M | -$8.3M |
| Diluted EPS | -$0.27 | $0.09 | -$0.17 | -$0.12 |
Biomea Fusion Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $145.7M | $111.9M | $176.9M | $58.3M | $55.8M |
| Current Assets | $176.6M | $117.8M | $179.2M | $68.3M | $58.0M |
| Total Assets | $185.7M | $129.3M | $199.9M | $79.9M | $58.6M |
| Current Liabilities | $4.6M | $19.1M | $22.9M | $21.7M | $11.1M |
| Total Liabilities | $6.9M | $20.8M | $30.7M | $28.4M | $29.0M |
| Shareholders' Equity | $178.8M | $108.5M | $169.2M | $51.6M | $29.6M |
Biomea Fusion Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$35.4M | -$62.4M | -$96.6M | -$119.9M | -$70.4M |
| Cash From Investing | -$33.4M | $27.3M | -$2.2M | -$362,000 | — |
| Cash From Financing | $153.2M | $1.2M | $163.8M | $1.7M | $67.9M |
| Free Cash Flow | -$38.6M | -$63.4M | -$100.0M | -$120.3M | -$70.7M |
Figures from Biomea Fusion's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Biomea Fusion financials page for every line item.
Biomea Fusion Company Profile
| Ticker | BMEA |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | San Carlos, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001840439 |
Frequently Asked Questions
What was Biomea Fusion's revenue in fiscal 2025?
Biomea Fusion (BMEA) reported revenue of $0 for fiscal 2025.
What is Biomea Fusion's annual revenue history?
Biomea Fusion's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Biomea Fusion's net income in fiscal 2025?
Biomea Fusion reported net income of -$61.8M for fiscal 2025.
What was Biomea Fusion's earnings per share (EPS) in fiscal 2025?
Biomea Fusion's diluted EPS was -$1.18 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Biomea Fusion generate in fiscal 2025?
Biomea Fusion generated -$70.7M of free cash flow in fiscal 2025.
What was Biomea Fusion's revenue last quarter?
In its most recent reported quarter (2026 Q2), Biomea Fusion reported revenue of $0.
How many shares of Biomea Fusion are outstanding?
Biomea Fusion reported a weighted average of 72.4 million basic shares outstanding in 2026 Q2.
What is Biomea Fusion's market cap?
Based on its latest closing price, Biomea Fusion (BMEA) has a market capitalization of about $91.2M.
When does Biomea Fusion's fiscal year end?
Biomea Fusion's fiscal year end, as registered with the SEC, is December 31.
Where is Biomea Fusion headquartered?
Biomea Fusion lists its business address in San Carlos, California in its SEC filings.